# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Ann Richards (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML019-SYN-TD
- Date: 1997-02-10
- Fictional facility: St. Posthumous Health Center
- Fictional author: Rosalind Teague, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Reason for visit

New patient visit for bone health after a fall with a hand fracture. **S**

## Historical basis

- Ann Richards was born Dorothy Ann Willis on September 1, 1933, in Lakeview, near Waco, Texas. **D**
- She was elected Texas state treasurer in 1982, gave the keynote address at the 1988 Democratic National Convention, was elected governor of Texas in 1990, and served one term after losing her bid for re-election in 1994. **D**
- She spoke openly about her past heavy drinking ("I smoked like a chimney and drank like a fish"), entered treatment, and emerged sober; one biography dates the treatment to 1980 and describes it as successful. **D**
- She said publicly that her mother had osteoporosis, broke "her arm, her hip," and developed a hump, and that osteoporosis was not the cause of her mother's death but led to it. **D**
- Because of her mother's fractures, she asked her doctor at an annual checkup to test her bone density. **D**
- She had a bone density test after falling and breaking her hand. CBS News (2003) and a publisher's summary date this to 1996, and CBS says she fell twice and broke her hand and her ankle; a Publishers Weekly review dates the hand fracture to 1994. **D**
- The bone density test showed osteopenia, which CBS News and the publisher's summary call an early stage of osteoporosis; in other interviews she said she had osteoporosis or early osteoporosis. **D**

4 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- She does not want to break bones and lose her posture the way her mother did. **S**
- She wants to keep traveling and speaking without slowing down, and wants a plan she can keep on the road. **S**

## Strengths and supports

- Engagement in care and meaningful activity **S**

## Medications and allergies

- Cholecalciferol (vitamin D3) 50 mcg (1971 units) oral tablet, one tablet daily **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- 1980: Heavy drinking, followed by treatment from which she emerged sober; no alcohol since **D** (CLM-0003)
- 1996: Fall with a hand fracture (one account also describes a second fall with an ankle fracture); the year is 1996 in two sources and 1994 in one **D** (CLM-0006)
- 1996: Bone density test after the fall, reported as osteopenia, an early stage of osteoporosis; no report or T-scores available **D** (CLM-0005, CLM-0007)

## Procedures and immunizations

- 1997-02-10 to 1997-02-10: Dual-energy X-ray absorptiometry of the lumbar spine and hip: L1-L4 T-score -2.3, femoral neck -2.0, total hip -1.7 (low bone mass) **S**
- 1997-02-10 to 1997-02-10: Vertebral fracture assessment by lateral spine DXA, T4 to L4: no vertebral fracture; mild degenerative change **S**
- 1996-10-14: Influenza vaccine, 1996-1997 season **S**
- 1994-05-16: Recombinant zoster vaccine, two-dose series completed **S**
- 1990-06-11: Tdap vaccine **S**

## Family history

- mother: Osteoporosis with fractures of the arm and hip and a curved upper back, by Richards's own public account; Richards said osteoporosis was not the cause of her mother's death but led to it **D** (CLM-0004)

## Measurements

Lumbar spine (L1-L4) T-score: -2.3 (low); Femoral neck T-score: -2 (low); Total hip T-score: -1.7 (low); FRAX 10-year major osteoporotic fracture risk: 22%; FRAX 10-year hip fracture risk: 3.6%; Calcium: 9.4 mg/dL; Albumin: 4.2 g/dL; Creatinine: 0.8 mg/dL; eGFR: 81 mL/min/1.73 m²; Phosphate: 3.5 mg/dL; Magnesium: 2 mg/dL; Alkaline phosphatase: 84 U/L; PTH: 54 pg/mL; TSH: 1.9 mIU/L; Hemoglobin: 13.3 g/dL; ALT: 21 U/L; 25-hydroxyvitamin D: 24 ng/mL (low); Serum CTX (fasting morning sample): 560 pg/mL; PHQ-9: 2; AUDIT-C: 0. All results are synthetic.

BP 124/76 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 66 kg; BMI 24.5 kg/m². All vital signs are synthetic.

## Examination

Mental status: Alert, quick-witted, and direct; asks pointed questions about her numbers; Mood good; PHQ-9 score 2 with item 9 scored 0; no thoughts of suicide or self-harm; no cravings. Functional status: Independent in all activities of daily living and instrumental activities. Timed Up and Go 11 seconds; tandem stance held 8 seconds (below 10); 30-second chair stand 11; fall with fracture in the past year and fear of another fall when traveling; Standing height 164.0 cm by stadiometer, about 2 cm below her recalled tallest height of 166 cm; no kyphosis; occiput touches the wall. Physical examination is intentionally limited. **S**

## Safety assessment

Current ideation: absent; intent: absent; plan: absent; access reviewed: yes. Disposition: Routine outpatient care. Crisis resources, including the 988 Suicide & Crisis Lifeline, given in writing and saved in her phone; safety reviewed at each visit. This is synthetic and does not convert historical behavior into a current finding. **S**

## Assessment

1. Low bone mass (osteopenia) of the lumbar spine and hip on DXA, lowest T-score -2.3 at the lumbar spine (femoral neck -2.0, total hip -1.7), with a 10-year FRAX risk above the treatment thresholds (major osteoporotic fracture 22 percent, hip 3.6 percent); not osteoporosis by T-score, but meets the AACE 1991 clinical criteria for osteoporosis (low bone mass with a FRAX risk above threshold); status draft. **S**
2. Alcohol use disorder in sustained remission for more than fifteen years, since treatment; no alcohol since; status draft. **S**
3. History of falls: a fall from standing height with a hand fracture last year (and, in one account, a second fall with an ankle fracture); no falls since; status draft. **S**

## Plan

- Endocrinology consultation to confirm the diagnostic category from the T-scores and FRAX, the risk category, the choice of drug, the secondary-causes work-up, and the plan for monitoring and treatment duration. Guideline: CMID: Clinical Monitoring Intelligence Database, osteoporosis monograph (2026); The clinician's guide to prevention and treatment of osteoporosis (2022); American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis, 2020 Update (2020); Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline (2019) **S**
- Calcium about 1200 mg a day in total, from food first, and vitamin D3 1971 units a day to reach 30 ng/mL or more, then continue; caffeine kept to two cups of coffee a day; no tobacco or alcohol. Guideline: CMID: Clinical Monitoring Intelligence Database, osteoporosis monograph (2026); The clinician's guide to prevention and treatment of osteoporosis (2022); American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis, 2020 Update (2020) **S**
- Falls prevention by CDC STEADI: supervised balance and strength exercise with a physical therapist for eight weeks, then a home program three times a week; weight-bearing exercise most days; home safety review (stair rails, night lights, no loose rugs); low-heeled shoes when traveling; yearly vision check. Guideline: The clinician's guide to prevention and treatment of osteoporosis (2022); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024); STEADI: Stopping Elderly Accidents, Deaths, and Injuries (2026) **S**
- Monitoring on the CMID osteoporosis schedule: secondary-causes tests at baseline (calcium, albumin, phosphate, magnesium, alkaline phosphatase, creatinine and eGFR, PTH, 25-hydroxyvitamin D, TSH, blood count, and 24-hour urine calcium); calcium and creatinine before each infusion; fasting CTX at baseline and three to six months after starting; 25-hydroxyvitamin D after repletion and then yearly; height and fall-risk screen yearly; FRAX recalculated when risk factors change; DXA of the spine and hip two years after starting, on the same scanner. Guideline: CMID: Clinical Monitoring Intelligence Database, osteoporosis monograph (2026); American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis, 2020 Update (2020); Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline (2019); Osteoporosis to Prevent Fractures: Screening (2025) **S**
- Recovery-oriented care for alcohol use disorder in sustained remission: ask about alcohol, cravings, and stress at each visit in a non-judgmental way, support the recovery practices she uses, avoid sedating medicines, and review safety with the 988 Suicide & Crisis Lifeline at each visit. Guideline: CMID: Clinical Monitoring Intelligence Database, osteoporosis monograph (2026); VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024) **S**

## Guideline basis

- CMID: Clinical Monitoring Intelligence Database, osteoporosis monograph (2026), Aether Forge
- The clinician's guide to prevention and treatment of osteoporosis (2022), Bone Health and Osteoporosis Foundation (LeBoff MS et al., Osteoporos Int 2022;33(10):2049-2102)
- American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis, 2020 Update (2020), AACE/ACE (Camacho PM et al., Endocr Pract 2020;26(Suppl 1):1-46)
- Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline (2019), Endocrine Society (Eastell R et al., J Clin Endocrinol Metab 2019;104(5):1595-1622)
- Osteoporosis to Prevent Fractures: Screening (2025), U.S. Preventive Services Task Force
- Falls Prevention in Community-Dwelling Older Adults: Interventions (2024), U.S. Preventive Services Task Force
- STEADI: Stopping Elderly Accidents, Deaths, and Injuries (2026), Centers for Disease Control and Prevention
- VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021), United States Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
